The rate of bi-allelic loss for the 15 HRR candidate genes by tumour type is shown in Fig. 3b, BRCA2 generally showed high bi-allelic loss rate across tumour types, ranging from 44% in bladder to 90% in ovarian cancer. This evidence concerns the gene BRCA2 and neoplasm.